Merry L Lindsey Selected Research

Matrix Metalloproteinase 9 (Gelatinase B)

1/2021	Infarct in the Heart: What's MMP-9 Got to Do with It?
1/2018	Macrophage overexpression of matrix metalloproteinase-9 in aged mice improves diastolic physiology and cardiac wound healing after myocardial infarction.
3/2017	Transgenic overexpression of macrophage matrix metalloproteinase-9 exacerbates age-related cardiac hypertrophy, vessel rarefaction, inflammation, and fibrosis.
11/2016	Early matrix metalloproteinase-9 inhibition post-myocardial infarction worsens cardiac dysfunction by delaying inflammation resolution.
8/2015	The circular relationship between matrix metalloproteinase-9 and inflammation following myocardial infarction.
8/2015	Building a better infarct: Modulation of collagen cross-linking to increase infarct stiffness and reduce left ventricular dilation post-myocardial infarction.
11/2014	Citrate synthase is a novel in vivo matrix metalloproteinase-9 substrate that regulates mitochondrial function in the postmyocardial infarction left ventricle.
11/2014	P. gingivalis lipopolysaccharide intensifies inflammation post-myocardial infarction through matrix metalloproteinase-9.
1/2014	Using plasma matrix metalloproteinase-9 and monocyte chemoattractant protein-1 to predict future cardiovascular events in subjects with carotid atherosclerosis.
11/2013	Matrix metalloproteinase-9: Many shades of function in cardiovascular disease.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Merry L Lindsey Research Topics

Disease

57	Myocardial Infarction 01/2022 - 02/2002
32	Infarction (Infarctions) 01/2022 - 02/2002
28	Inflammation (Inflammations) 01/2022 - 04/2011
16	Cicatrix (Scar) 01/2022 - 01/2003
14	Heart Failure 01/2022 - 01/2008
13	Fibrosis (Cirrhosis) 01/2021 - 03/2008
10	Ventricular Remodeling 01/2021 - 02/2002
9	Hypertension (High Blood Pressure) 10/2021 - 03/2008
8	Cardiovascular Diseases (Cardiovascular Disease) 06/2015 - 06/2007
7	Hypertrophy 07/2014 - 04/2006
4	Neoplasms (Cancer) 01/2022 - 06/2007
3	Obesity 01/2022 - 08/2012
3	Left Ventricular Dysfunction 01/2017 - 04/2008
3	Atherosclerosis 02/2014 - 12/2012
2	Cardiomegaly (Heart Hypertrophy) 01/2021 - 03/2017
2	Pathologic Processes 12/2014 - 11/2014
2	Cardiomyopathies (Cardiomyopathy) 11/2014 - 01/2012
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 08/2012 - 01/2012
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2012 - 01/2008
2	Reperfusion Injury 01/2012 - 01/2008
1	Prostatic Neoplasms (Prostate Cancer) 01/2022
1	Dysbiosis 04/2021
1	Congenital Heart Defects (Congenital Heart Defect) 04/2021
1	Proteinuria 01/2020
1	Chronic Renal Insufficiency 01/2020
1	Acute-Phase Reaction 01/2019
1	Mental Disorders (Mental Disorder) 01/2019
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2019

Drug/Important Bio-Agent (IBA)

36	Matrix Metalloproteinases (MMPs)IBA 01/2022 - 02/2002
19	CollagenIBA 01/2018 - 02/2002
17	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2006
16	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2021 - 08/2005
6	LipopolysaccharidesIBA 11/2021 - 10/2013
6	CytokinesIBA 01/2021 - 01/2012
6	Biomarkers (Surrogate Marker)IBA 01/2019 - 07/2013
5	Biological ProductsIBA 01/2019 - 01/2011
4	Peptide Hydrolases (Proteases)FDA Link 01/2022 - 01/2015
4	Glycoproteins (Glycoprotein)IBA 01/2022 - 08/2014
4	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2018
4	Fibronectins (Fibronectin)IBA 01/2021 - 03/2008
4	Pharmaceutical PreparationsIBA 08/2014 - 08/2012
4	Metalloproteases (Metalloproteinases)IBA 02/2014 - 01/2008
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 01/2014
3	Galectin 3 (LGALS3)IBA 01/2022 - 01/2019
3	Angiotensin IIIBA 10/2021 - 01/2019
3	SaltsIBA 01/2020 - 03/2008
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2018 - 12/2012
3	ChemokinesIBA 01/2018 - 04/2011
3	EnzymesIBA 02/2016 - 08/2013
2	AntioxidantsIBA 01/2022 - 12/2018
2	Fibrinogen (Factor I)FDA Link 01/2022 - 01/2019
2	FatsIBA 01/2022 - 01/2012
2	EndotoxinsIBA 11/2021 - 01/2017
2	Liver X ReceptorsIBA 01/2019 - 01/2018
2	apolipoprotein FIBA 01/2019 - 01/2018
2	Retinoid X Receptors (Retinoid X Receptor)IBA 01/2019 - 01/2018
2	ProteomeIBA 01/2019 - 09/2010
2	ApolipoproteinsIBA 01/2018 - 01/2015
2	Messenger RNA (mRNA)IBA 01/2018 - 02/2013
2	InterleukinsIBA 01/2017 - 04/2011
2	Cysteine (L-Cysteine)FDA Link 01/2016 - 06/2015
2	Lactic Acid (Lactate)FDA LinkGeneric 10/2015 - 01/2012
2	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 08/2015 - 02/2013
2	Adenosine Triphosphate (ATP)IBA 01/2014 - 01/2012
2	Griffonia simplicifolia lectinsIBA 11/2013 - 01/2006
2	Fish OilsIBA 08/2012 - 04/2011
2	ThioredoxinsIBA 01/2012 - 04/2006
2	Matrix Metalloproteinase 7 (Matrilysin)IBA 05/2010 - 06/2006
1	Docosahexaenoic AcidsIBA 01/2022
1	CreatinineIBA 01/2022
1	AndrogensIBA 01/2022
1	ThromboxanesIBA 01/2022
1	Histones (Histone)IBA 01/2022
1	ProstaglandinsIBA 01/2022
1	Glutathione (Reduced Glutathione)IBA 01/2022
1	Safflower Oil FDA Link 01/2022
1	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2022
1	Apolipoproteins D (Apo D)IBA 01/2022
1	c-Mer Tyrosine KinaseIBA 11/2021
1	Immunoglobulin G (IgG)IBA 11/2021
1	NG-Nitroarginine Methyl Ester (L-NAME)IBA 10/2021
1	Enalapril FDA LinkGeneric 01/2021
1	VimentinIBA 01/2021
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2021
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2021
1	Complement System Proteins (Complement)IBA 01/2020
1	Interleukin-4 (Interleukin 4)IBA 01/2020
1	Guanine Nucleotide Exchange Factors (Guanine Nucleotide Exchange Factor)IBA 01/2020
1	hydroxide ionIBA 11/2019
1	Hormones (Hormone)IBA 11/2019
1	InflammasomesIBA 11/2019
1	Complement C5 (Complement 5)IBA 01/2019
1	laminin 1IBA 01/2019
1	lymphotactinIBA 01/2019
1	Pyrrolidonecarboxylic Acid (Pyroglutamic Acid)IBA 12/2018

Therapy/Procedure

6	Therapeutics 01/2019 - 01/2012
3	Ligation 01/2019 - 01/2012
1	Cardiopulmonary Bypass (Heart-Lung Bypass) 04/2021
1	Length of Stay 01/2019